WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019

WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine

doi:10.1038/s41541-020-0197-2

WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019

WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Article number	52
Journal	npj Vaccines
Volume	5
Issue number	1
DOIs	https://doi.org/10.1038/s41541-020-0197-2
State	Published - Dec 1 2020

ASJC Scopus subject areas

Immunology
Pharmacology
Infectious Diseases
Pharmacology (medical)

Access to Document

10.1038/s41541-020-0197-2

Cite this

WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019. / WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine.
In: npj Vaccines, Vol. 5, No. 1, 52, 01.12.2020.

Research output: Contribution to journal › Article › peer-review

@article{20b6c03286f64472aedfa8f94e5c3a21,

title = "WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019",

author = "{WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine} and Rebecca Sheets and Kang, {Hye Na} and Heidi Meyer and Ivana Knezevic and Edward Abwao and Mohammed Alali and Patricia Aprea and Changjoon Bae and Blades, {Carolina Damas Rocha Zarate} and Jean Boyer and Broderick, {Kate E.} and Patrick Duffy and Aaron Farnsworth and Jayant Gangakhedkar and David Gutsch and Hafiz, {Radwan A.} and Nick Jackson and Kang, {Hye Na} and David Kaslow and Khan, {Amir S.} and Ivana Knezevic and Julie Ledgerwood and Liu, {Margaret A.} and Joel Maslow and Heidi Meyer and Edwin Nkansah and Young Park and Ami Patel and Keith Peden and Trina Racine and Nicola Rose and Polly Roy and Rebecca Sheets and Manki Song and Wei Wei",

note = "Funding Information: The authors would like to acknowledge funding support for this project from the Center for Biologics Evaluation and Research (CBER)—U.S. Food and Drug Administration (grant number U01 FD005959). The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.",

year = "2020",

month = dec,

day = "1",

doi = "10.1038/s41541-020-0197-2",

language = "English (US)",

volume = "5",

journal = "npj Vaccines",

issn = "2059-0105",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019

AU - WHO informal consultation on development of guidelines for assuring the quality, safety, and efficacy of DNA vaccine

AU - Sheets, Rebecca

AU - Kang, Hye Na

AU - Meyer, Heidi

AU - Knezevic, Ivana

AU - Abwao, Edward

AU - Alali, Mohammed

AU - Aprea, Patricia

AU - Bae, Changjoon

AU - Blades, Carolina Damas Rocha Zarate

AU - Boyer, Jean

AU - Broderick, Kate E.

AU - Duffy, Patrick

AU - Farnsworth, Aaron

AU - Gangakhedkar, Jayant

AU - Gutsch, David

AU - Hafiz, Radwan A.

AU - Jackson, Nick

AU - Kang, Hye Na

AU - Kaslow, David

AU - Khan, Amir S.

AU - Knezevic, Ivana

AU - Ledgerwood, Julie

AU - Liu, Margaret A.

AU - Maslow, Joel

AU - Meyer, Heidi

AU - Nkansah, Edwin

AU - Park, Young

AU - Patel, Ami

AU - Peden, Keith

AU - Racine, Trina

AU - Rose, Nicola

AU - Roy, Polly

AU - Sheets, Rebecca

AU - Song, Manki

AU - Wei, Wei

N1 - Funding Information: The authors would like to acknowledge funding support for this project from the Center for Biologics Evaluation and Research (CBER)—U.S. Food and Drug Administration (grant number U01 FD005959). The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.

PY - 2020/12/1

Y1 - 2020/12/1

UR - http://www.scopus.com/inward/record.url?scp=85087076963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85087076963&partnerID=8YFLogxK

U2 - 10.1038/s41541-020-0197-2

DO - 10.1038/s41541-020-0197-2

M3 - Article

AN - SCOPUS:85087076963

SN - 2059-0105

VL - 5

JO - npj Vaccines

JF - npj Vaccines

IS - 1

M1 - 52

ER -

WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this